Manage Tickers

Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current
Analyst Rating Guide

News

Back

12 Health Care Stocks Moving In Tuesday's After-Market Session

Author: Benzinga Insights | September 20, 2022 05:35pm

Gainers

  • CinCor Pharma (NASDAQ:CINC) shares moved upwards by 19.5% to $33.0 during Tuesday's after-market session. The market value of their outstanding shares is at $1.4 billion.
  • GlycoMimetics (NASDAQ:GLYC) shares moved upwards by 13.54% to $0.74. The market value of their outstanding shares is at $38.6 million.
  • Kiora Pharmaceuticals (NASDAQ:KPRX) stock increased by 11.04% to $0.2. Today's trading volume for this security ended up closing at 193.4K shares, which is 1.9 percent of its average volume over the last 100 days. The market value of their outstanding shares is at $7.3 million.
  • Ainos (NASDAQ:AIMD) shares rose 10.49% to $1.79. The company's market cap stands at $34.8 million.
  • ENDRA Life Sciences (NASDAQ:NDRA) shares increased by 7.49% to $0.33. The market value of their outstanding shares is at $20.8 million.
  • Cidara Therapeutics (NASDAQ:CDTX) shares moved upwards by 6.99% to $0.82. The market value of their outstanding shares is at $57.8 million.

Losers

  • HTG Molecular Diagnostics (NASDAQ:HTGM) shares declined by 10.9% to $0.62 during Tuesday's after-market session. The market value of their outstanding shares is at $6.8 million.
  • NeuroBo Pharmaceuticals (NASDAQ:NRBO) shares declined by 7.12% to $19.31. The market value of their outstanding shares is at $17.3 million.
  • Statera BioPharma (NASDAQ:STAB) stock decreased by 6.26% to $0.15. The company's market cap stands at $7.5 million.
  • NeuroOne Medical Tech (NASDAQ:NMTC) stock decreased by 6.1% to $1.85. The market value of their outstanding shares is at $29.9 million.
  • Summit Therapeutics (NASDAQ:SMMT) stock declined by 5.93% to $1.27. The company's market cap stands at $255.5 million.
  • Revelation Biosciences (NASDAQ:REVB) stock decreased by 5.02% to $0.3. The company's market cap stands at $7.0 million. See Also: www.benzinga.com/money/best-healthcare-stocks/

This article was generated by Benzinga's automated content engine and reviewed by an editor.

Posted In: AIMD CDTX CINC GLYC HTGM KPRX NDRA NMTC NRBO REVB SMMT STAB


CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist